Labcorp Holdings Inc

LH

Add to Watchlist

255.035USD

-2.315-0.90%

Market hours （ET）Quotes delayed by 15 min

Labcorp Holdings Inc's Score

Industry at a Glance

Industry Ranking

15 / 75

Overall Ranking

82 / 4490

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative-

Labcorp Holdings Inc Highlights

StrengthsRisks

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 13.95B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.

Undervalued

The company’s latest PE is 22.64, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 88.74M shares, increasing 5.91% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 734.00 shares of this stock.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

308.032

Target Price

+21.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Labcorp Holdings Inc is 8.85, ranking 5 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 3.54B, representing a year-over-year increase of 5.75%, while its net profit experienced a year-over-year increase of 30.55%.

Score

Industry at a Glance

Previous score

8.85

Change

0



Financials

6.74

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.72

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.18

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.60

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Labcorp Holdings Inc is 5.66, ranking 67 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 22.64, which is 114.00% below the recent high of 48.46 and 42.36% above the recent low of 13.05.

Score

Industry at a Glance

Previous score

5.66

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 15/75

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Labcorp Holdings Inc is 8.19, ranking 24 out of 75 in the Healthcare Providers & Services industry. The average price target is 304.00, with a high of 342.00 and a low of 260.00.

Score

Industry at a Glance

Previous score

8.19

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Labcorp Holdings Inc is 7.11, ranking 48 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 275.18 and the support level at 244.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.91

Change

0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Labcorp Holdings Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 108.22%, representing a quarter-over-quarter increase of 9.95%. The largest institutional shareholder is Invesco, holding a total of 972.87K shares, representing 1.19% of shares outstanding, with 13.64% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Victory Capital Management Inc.

5.36M

+103.11%

BlackRock Institutional Trust Company, N.A.

4.43M

+0.76%

State Street Investment Management (US)

3.83M

-0.15%

Boston Partners

1.91M

+52.75%

Allspring Global Investments, LLC

2.20M

+10.42%

Geode Capital Management, L.L.C.

2.14M

+0.65%

Select Equity Group, L.P.

2.11M

+14.90%

Wellington Management Company, LLP

1.96M

-6.78%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Labcorp Holdings Inc is 8.79, ranking 5 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.91. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Labcorp Holdings Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Labcorp Holdings Inc

LH

8.00 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cigna Group

CI

8.63 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Encompass Health Corp

EHC

8.62 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Concentra Group Holdings Parent Inc

CON

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lifestance Health Group Inc

LFST

8.40 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Sotera Health Co

SHC

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment